Evaluating the effects of platelet-rich plasmas plus dehydroepiandrosterone and dehydroepiandrosterone alone in infertile women with diminished ovarian reserve

Sohely Akter; Shaheen A. Anwary; Amitun Nessa; Rebeka Sultana; Suraiya J. Rolly; Mostafa M. Altarique; Chowdhury F. Alamgir; Maliha Darmini; Jesmine Banu

doi:10.18203/2320-1770.ijrcog20251964

Authors

Sohely Akter Department of Reproductive Endocrinology and Infertility, Directorate General of Health Services (OSD), Dhaka, Bangladesh
Shaheen A. Anwary Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University, Dhaka, Bangladesh
Amitun Nessa Department of Reproductive Endocrinology and Infertility, Directorate General of Health Services (OSD), Dhaka, Bangladesh
Rebeka Sultana Department of Reproductive Endocrinology and Infertility, Directorate General of Health Services (OSD), Dhaka, Bangladesh
Suraiya J. Rolly Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University, Dhaka, Bangladesh
Mostafa M. Altarique Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University, Dhaka, Bangladesh
Chowdhury F. Alamgir Department of Urology, New Cross Hospital, The Royal Wolverhampton NHS Trust, United Kingdom
Maliha Darmini Department of Gynecology, Mymensingh Medical College and Hospital, Mymensingh, Bangladesh
Jesmine Banu Department of Reproductive Endocrinology and Infertility, Bangladesh Medical University, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20251964

Keywords:

Diminished ovarian reserve, Platelet-rich plasma, Dehydroepiandrosterone, Infertility

Abstract

Background: Diminished ovarian reserve (DOR) is a significant cause of female infertility, often associated with poor response to ovarian stimulation during assisted reproductive techniques. This study aimed to evaluate the effects of a combination therapy using platelet-rich plasma (PRP) and dehydroepiandrosterone (DHEA) compared to DHEA alone in infertile women with DOR.

Methods: This Quasi-experimental study was conducted in the Department of Reproductive Endocrinology and Infertility, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh, from July 2022 to June 2023. In this study, we included 36 women aged 20 to 39 years diagnosed with diminished ovarian reserve (DOR) attending the outpatient Department of Reproductive Endocrinology and Infertility at BSMMU. Participants were assigned to two treatment groups: group A received DHEA plus PRP, and group B received only DHEA.

Results: The mean age in group A was 31.5±5.5 years (range: 25–39), and in group B, it was 31.4±5.2 years (range: 25–39). Baseline characteristics, including age, body mass index (BMI), infertility duration, and hormonal levels, were similar between the groups. Over the 3-month follow-up, both groups showed improvements in ovarian reserve markers. Group A demonstrated slightly greater improvements in AMH (0.36±0.2 ng/ml versus 0.30±0.1 ng/ml), AFC (1.2±1.4 versus 0.82±1.5), and a greater reduction in FSH (-3.1±1.9 mIU/ml versus -2.82±1.7 mIU/ml) compared to group B. However, these differences were not statistically significant.

Conclusions: This study showed that both DHEA alone and in combination with PRP resulted in improved ovarian reserve markers in women with DOR. Although the combination therapy of PRP and DHEA showed slightly better outcomes compared to DHEA alone, the differences were not significant.

Metrics

Metrics Loading ...

References

Obeagu EI, Obeagu GU, Njar VE. Infertility: Prevalence and Consequences. Int J Curr Res Chem Pharm Sci. 2023;10(7):43-50. DOI: https://doi.org/10.22270/ijmspr.v10i4.123

World Health Organization (WHO). Infertility prevalence estimates. 2021. Available at: https://www.who.int/publications/i/item/978920068315. Accessed on 21 March 2025.

Choi R, Park W, Chun G, Lee SG, Lee EH. Investigation of the Prevalence of Diminished Ovarian Reserve in Korean Women of Reproductive Age. J Clin Med. 2023;12(15):5099. DOI: https://doi.org/10.3390/jcm12155099

Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys. PLoS Med. 2012;9(12):1-12. DOI: https://doi.org/10.1371/journal.pmed.1001356

Magdum M, Chowdhury MAT, Begum N, Riya S. Types of Infertility and Its Risk Factors among Infertile Women: A Prospective Study in Dhaka City. J Biosci Med. 2022;10(04):158-68. DOI: https://doi.org/10.4236/jbm.2022.104014

Uddin S, Wahed IIU, Haque SH, Nejum RA. Current Consequence and Research of Human Infertility in Bangladesh. J Reprod Endocrinol Infertil. 2018;3(1):1-8.

Purkayastha N, Sharma H. Prevalence and potential determinants of primary infertility in India: Evidence from Indian demographic health survey. Clin Epidemiol Glob Health. 2021;9(6):162-70. DOI: https://doi.org/10.1016/j.cegh.2020.08.008

Patel A, Sharma PSVN, Narayan P, Binu VS, Dinesh N, Pai PJ. Prevalence and predictors of infertility-specific stress in women diagnosed with primary infertility: A clinic-based study. J Hum Reprod Sci. 2016;9(1):28-34. DOI: https://doi.org/10.4103/0974-1208.178630

Qin X, Gong Y, Yu F, Song J, Dong S, Zhang R, et al. A comparison of the efficacy and safety of traditional Chinese medicine in preconditioning patients with diminished ovarian reserve that would undergo in vitro fertilization: A network meta-analysis protocol. Medicine (Baltimore). 2021;100(4):1-4. DOI: https://doi.org/10.1097/MD.0000000000024408

Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder a plea for universal definitions. J Assist Reprod Genet. 2015;32(12):1709-12. DOI: https://doi.org/10.1007/s10815-015-0595-y

Azhar E, Seifer DB, Melzer K, Ahmed A, Weedon J, Minkoff H. Knowledge of ovarian reserve and reproductive choices. J Assist Reprod Genet. 2015;32(3):409-15. DOI: https://doi.org/10.1007/s10815-014-0415-9

Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616-24. DOI: https://doi.org/10.1093/humrep/der092

Salih M, Hussein M, Tag Aldin A, Nouraldein M, Alla Eljack B, Mohammed H, et al. Correlation between antimullerian hormone level before and after laparoscopic ovarian autologous PRP injections. Evid Based Women’s Health J. 2020;10(1):89-94. DOI: https://doi.org/10.21608/ebwhj.2020.73814

Kara M, Aydin T, Aran T, Turktekin N, Ozdemir B. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve? Eur J Obstet Gynecol Reprod Biol. 2014;173:63-5. DOI: https://doi.org/10.1016/j.ejogrb.2013.11.008

Jahromi BN, Sadeghi S, Alipour S, Parsanezhad ME, Alamdarloo SM. Effect of Melatonin on the Outcome of Assisted Reproductive Technique Cycles in Women with Diminished Ovarian Reserve: A Double-Blinded Randomized Clinical Trial. Iran J Med Sci. 2017;42(1):73-8.

Pantos K, Nitsos N, Kokkali G, Vaxevanoglou T, Markomichali C, Pantou A, et al. Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment. Hum Reprod. 2016;31(Suppl 1):301. DOI: https://doi.org/10.26226/morressier.573c1512d462b80296c98880

Sills ES, Rickers NS, Li X, Palermo GD. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol. 2018;34(9):756-60. DOI: https://doi.org/10.1080/09513590.2018.1445219

Hu Q, Hong L, Nie M, Wang Q, Fang Y, Dai Y, et al. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women. J Ovarian Res. 2017;10(1):1-10. DOI: https://doi.org/10.1186/s13048-017-0326-3

Melo P, Navarro C, Jones C, Coward K, Coleman L. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study. J Assist Reprod Genet. 2020;37(4):855-63. DOI: https://doi.org/10.1007/s10815-020-01710-z

Uddin MJ, Banu J, Ishrat S, Sultana S, Munira S, Shume MM, et al. Effect of autologous platelet rich plasma on anti-mullerian hormone and antral follicle count in sub fertile women with poor ovarian reserve. Int J Reprod Contracept Obstet Gynecol. 2022;11(2):1-7. DOI: https://doi.org/10.18203/2320-1770.ijrcog20220033

Banu J, M M, Jahan N, Lasker N, Sultana N, Alamgir CF, et al. Efficacy of autologous platelet rich plasma for ovarian rejuvenation in infertile women having poor ovarian reserve. Int J Reprod Contracept Obstet Gynecol. 2022;11(11):1-6. DOI: https://doi.org/10.18203/2320-1770.ijrcog20222782

Liang S, Chen Y, Wang Q, Chen H, Cui C, Xu X, et al. Prevalence and associated factors of infertility among 20–49 year old women in Henan Province, China. Reprod Health. 2021;18(1):1-13. DOI: https://doi.org/10.1186/s12978-021-01298-2

Bisht BS. Evaluation of Antianxiety activity of Zonisamide based on the Serendipitous action in Swiss albino mice. Int J Curr Res Chem Pharm Sci. 2019;6(4):27-32.

Halder S, Ishrat S, Rahman F, Nasrin I, Amir M, Majumdar BK. Vitamin D Supplementation in women with Diminished Ovarian Reserve: A Randomized Controlled Trial. Int J Reprod Contracept Obstet Gynecol. 2022;11(10):2787-92. DOI: https://doi.org/10.18203/2320-1770.ijrcog20222370

Barad DH, Albertini DF, Molinari E, Gleicher N. Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study. Hum Reprod Open. 2022;2022(3):1-9. DOI: https://doi.org/10.1093/hropen/hoac027